Bone cancer: diagnosis and treatment principles
JL Ferguson, SP Turner - American family physician, 2018 - aafp.org
Primary bone cancers include osteosarcoma, Ewing sarcoma, and chondrosarcoma. They
account for less than 1% of diagnosed cancers each year and are associated with significant …
account for less than 1% of diagnosed cancers each year and are associated with significant …
Germline and somatic genetics of osteosarcoma—connecting aetiology, biology and therapy
DM Gianferante, L Mirabello, SA Savage - Nature Reviews …, 2017 - nature.com
Clinical outcomes and treatment modalities for osteosarcoma, the most common primary
cancer of bone, have changed very little over the past 30 years. The peak incidence of …
cancer of bone, have changed very little over the past 30 years. The peak incidence of …
Osteosarcoma: a surveillance, epidemiology, and end results program‐based analysis from 1975 to 2017
S Cole, DM Gianferante, B Zhu, L Mirabello - Cancer, 2022 - Wiley Online Library
Background Osteosarcoma is the most common primary bone malignancy. As a rare cancer,
population‐based studies remain small with limited information on finer demographic …
population‐based studies remain small with limited information on finer demographic …
Update on survival in osteosarcoma
ME Anderson - Orthopedic Clinics, 2016 - orthopedic.theclinics.com
Survival in osteosarcoma is a story of success on many fronts. What was once a disease that
was rarely curable even with ablative surgery now has a 5-year overall survival approaching …
was rarely curable even with ablative surgery now has a 5-year overall survival approaching …
lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition
N Jiang, X Wang, X Xie, Y Liao, N Liu, J Liu, N Miao… - Cancer letters, 2017 - Elsevier
Abstract lncRNAs regulate the initiation and progression of osteosarcoma, although the
mechanism by which this occurs remains unknown. The present study shows that over …
mechanism by which this occurs remains unknown. The present study shows that over …
An update on chemotherapy for osteosarcoma
S Ferrari, M Serra - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: In the early seventies chemotherapy significantly improved survival in
osteosarcoma. Since then minor innovations have occurred although recent years have …
osteosarcoma. Since then minor innovations have occurred although recent years have …
Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China
D Liu, Y Kuai, R Zhu, C Zhou, Y Tao, W Han, Q Chen - Scientific reports, 2020 - nature.com
Prostate cancer (PCa) is the leading cause of cancer-related death among men worldwide.
Knowledge of the prognostic factors of PCa and the bone metastasis pattern of patients …
Knowledge of the prognostic factors of PCa and the bone metastasis pattern of patients …
[HTML][HTML] Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice
S Xin, G Wei - Journal of Bone Oncology, 2020 - Elsevier
Background A consensus has not yet been reached regarding the abilities of gender, age,
tumor size, tumor location, histologic subtypes, and surgery in the prediction of survival in …
tumor size, tumor location, histologic subtypes, and surgery in the prediction of survival in …
Osteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes
Z Nie, H Peng - Oncology letters, 2018 - spandidos-publications.com
Only few systematic and comprehensive studies have focused on osteosarcoma in children
and adolescents. In the present study, 3,085 patients with osteosarcoma were identified in …
and adolescents. In the present study, 3,085 patients with osteosarcoma were identified in …
The role of m6A modification in pediatric cancer
With the development of RNA modification research, the importance of N6-methyladenosine
(m6A) in tumors cannot be ignored. m6A promotes the self-renewal of tumor stem cells and …
(m6A) in tumors cannot be ignored. m6A promotes the self-renewal of tumor stem cells and …